NEU neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-3

  1. 726 Posts.
    lightbulb Created with Sketch. 406
    I am not a doctor, ours is a pediatric study, theirs is for adults, they have another phase 2/3 pediatric study in progress, it should be compared with that when the data comes out

    https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/

    https://www.neurenpharma.com/irm/PD...ificantclinicalbenefitinpediatricRettsyndrome

    https://www.clinicaltrials.gov/ct2/...&cond=Rett Syndrome&draw=2&rank=1
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.28
Change
0.080(0.56%)
Mkt cap ! $1.777B
Open High Low Value Volume
$14.22 $14.55 $14.10 $4.611M 320.2K

Buyers (Bids)

No. Vol. Price($)
1 6352 $14.28
 

Sellers (Offers)

Price($) Vol. No.
$14.38 4000 1
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.